Litcius/Paper detail

Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer

Yoshimasa Shiraishi, Junji Kishimoto, Kentaro Tanaka, Shunichi Sugawara, Haruko Daga, Katsuya Hirano, Koichi Azuma, Osamu Hataji, Hidetoshi Hayashi, Motoko Tachihara, Tetsuya Mitsudomi, Takashi Seto, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Isamu Okamoto

2020Clinical Lung Cancer15 citationsDOI

Topics & Concepts

AtezolizumabPemetrexedMedicineBevacizumabOncologyOpen labelInternal medicineLung cancerPhases of clinical researchRandomized controlled trialCisplatinPembrolizumabChemotherapyCancerImmunotherapyCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment